Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

February 28, 2011

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Corona Gary Louis

2. Date of Event Requiring Statement (Month/Day/Year)
08/03/2024

3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [MDT]

(Last)

(First)

(Middle)

710 MEDTRONIC PARKWAY

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Interim CFO

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

MINNEAPOLIS, MN 55432

6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	24,069 ⁽¹⁾ ⁽²⁾	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	07/31/2024⁽³⁾	07/31/2033	Ordinary Shares	10,164	$ 87.76	D
Stock Option (Right to Buy)	07/29/2025⁽³⁾	07/29/2034	Ordinary Shares	1,540	$ 80	D
Performance Share Unit	⁽⁴⁾	⁽⁴⁾	Ordinary Shares	3,245 ⁽⁵⁾	$ ⁽⁶⁾	D
Performance Share Unit	⁽⁷⁾	⁽⁷⁾	Ordinary Shares	3,125 ⁽⁸⁾	$ ⁽⁶⁾	D
Performance Share Unit	⁽⁹⁾	⁽⁹⁾	Ordinary Shares	6,250 ⁽¹⁰⁾	$ ⁽⁶⁾	D

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Corona Gary Louis 710 MEDTRONIC PARKWAY MINNEAPOLIS, MN 55432			Interim CFO

Signatures

/s/ Thomas L. Osteraas, attorney-in-fact		08/12/2024
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 432 shares purchased pursuant to Medtronic's Employee Stock Ownership Plan.
(2)	Includes 6,438 restricted stock units that vest in three annual installments beginning on December 6, 2024; 4,249 restricted stock units that vest on July 10, 2025; 1,298 restricted stock units that vest on July 31, 2026; and 6,250 restricted stock units that vest on July 29, 2027.
(3)	These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
(4)	The performance share units vest on April 24, 2026.
(5)	The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,245 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
(6)	Each performance share unit represented a contingent right to receive one share of Medtronic common stock.
(7)	The performance share units vest on December 6, 2026.
(8)	The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,125 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
(9)	The performance share units vest on April 30, 2027.
(10)	The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 6,250 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.